Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV‐2 infection is a research paper published in Respirology (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: HB2‐164064
Canadian Institutes of Health Research
Grant: MOP‐114957
Canadian Institutes of Health Research
Grant: PJT‐153052
National Institutes of Health
Grant: R01AG054324
CIHR
Grant: MOP-114957
CIHR
Grant: PJT-153052
CIHR
Grant: HB2-164064
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AG054324-02
Exploring the role of IL-32 as a potential biomarker and therapeutic target in premature cardio-vascular diseases during HIV-infection.
University of Montreal
Centre for Research on Intermediality, University of Montreal
Fonds de Recherche du Québec - Santé
Fields of Study
Keywords